PROSPECTIVE-STUDY OF PLASMA FATTY-ACIDS AND RISK OF PROSTATE-CANCER

被引:271
|
作者
GANN, PH
HENNEKENS, CH
SACKS, FM
GRODSTEIN, F
GIOVANNUCCI, EL
STAMPFER, MJ
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DIV PREVENT MED,BOSTON,MA 02115
[2] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,CHANNING LAB,BOSTON,MA 02115
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,BOSTON,MA 02115
[4] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT AMBULATORY CARE & PREVENT,BOSTON,MA 02115
[5] HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115
关键词
D O I
10.1093/jnci/86.4.281
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although some evidence suggests that dietary fat intake is related to prostate cancer, epidemiologic studies have been inconsistent. Purpose: Our purpose was to assess the association between plasma lipid levels, particularly linoleic and alpha-linolenic acids, and the development of prostate cancer. Methods: In 1982, at the start of the Physicians' Health Study, 14916 U.S. male physicians provided plasma samples, which were frozen at -82-degrees-C. Data accumulated from a series of questionnaires were used to assess the intake of various foods. We used a nested case-control design to compare the fatty acid compositions in plasma from 120 men who later developed prostate cancer with 120 matched controls who did not. Individual fatty acids were measured in plasma as a percentage of total fatty acids, using capillary gas chromatography. Conditional logistic regression models were used to obtain odds ratio estimates while adjusting simultaneously for the effects of one or more potential confounders. Results: The relative risks (RRs) of prostate cancer for men in successively higher quartiles of plasma alpha-linolenic acid level were 3.0 (95% confidence interval [CI] = 1.2-7.3), 3.4 (95% CI = 1.6-7.5), and 2.1 (95% CI = 0.9-4.9), compared with those with levels below the detection threshold (P trend = .03). For linoleic acid, RRs in successively higher quartiles were 0.7 (95% CI = 0.4-1.5), 0.8 (95% CI = 0.4-1.6), and 0.6 (95% CI = 0.3-1.3), with the lowest quartile as referent (P trend = .24). The effect estimates were not notably altered by adjustment for exercise, body mass, meat and dairy consumption, or other fatty acid levels in the plasma. The RR for eating red meat at least five times per week compared with less than once a week was 2.5 (95% CI = 0.9-6.7) and was little changed by adjustment for alpha-linolenic acid, although alpha-linolenic acid levels were correlated with intake of red meat and butter. The association of alpha-linolenic acid levels with prostate cancer was greater among men with low linoleic acid and reduced meat intake. Conclusions: These results suggest that low plasma levels of alpha-linolenic acid might be associated with reduced risk of prostate cancer, independently of high meat intake. High linoleic acid and low marine fatty oils were not associated with increased risk, as previously hypothesized. Implications: The effects of dietary alpha-linolenic acid, particularly from vegetable sources, warrant further study. The effects of dietary linoleic acid and marine fatty acids seen in animal bioassays might not apply to human prostate cancer.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 50 条
  • [21] Re: Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial
    Sosnowski, Roman
    Zawistowski, Jerzy
    EUROPEAN UROLOGY, 2014, 65 (05) : 1012 - 1012
  • [22] Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition
    Perez-Cornago, Aurora
    Huybrechts, Inge
    Appleby, Paul N.
    Schmidt, Julie A.
    Crowe, Francesca L.
    Overvad, Kim
    Tjonneland, Anne
    Kuehn, Tilman
    Katzke, Verena
    Trichopoulou, Antonia
    Karakatsani, Anna
    Peppa, Eleni
    Grioni, Sara
    Palli, Domenico
    Sacerdote, Carlotta
    Tumino, Rosario
    Bueno-de-Mesquita, H. Bas
    Larranaga, Nerea
    Sanchez, Maria-Jose
    Ramon Quiros, J.
    Ardanaz, Eva
    Chirlaque, Maria-Dolores
    Agudo, Antonio
    Bjartell, Anders
    Wallstrom, Peter
    Chajes, Veronique
    Tsilidis, Konstantinos K.
    Aune, Dagfinn
    Riboli, Elio
    Travis, Ruth C.
    Key, Timothy J.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (01) : 44 - 57
  • [23] SEAFOOD FATTY-ACIDS MAY LOWER CANCER RISK
    CORLISS, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (20) : 1530 - 1531
  • [24] The association of fatty acids with prostate cancer risk
    Newcomer, LM
    King, IB
    Wicklund, KG
    Stanford, JL
    PROSTATE, 2001, 47 (04): : 262 - 268
  • [25] A prospective study of plasma selenium levels and prostate cancer risk
    Li, HJ
    Stampfer, MJ
    Giovannucci, EL
    Morris, JS
    Willett, WC
    Gaziano, JM
    Ma, J
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (09): : 696 - 703
  • [26] Prospective study of plasma enterolactone and prostate cancer risk (Sweden)
    Pär Stattin
    Annika Bylund
    Carine Biessy
    Rudolf Kaaks
    Göran Hallmans
    Herman Adlercreutz
    Cancer Causes & Control, 2004, 15 : 1095 - 1102
  • [27] Prospective study of plasma enterolactone and prostate cancer risk (Sweden)
    Stattin, P
    Bylund, A
    Biessy, C
    Kaaks, R
    Hallmans, G
    Adlercreutz, H
    CANCER CAUSES & CONTROL, 2004, 15 (10) : 1095 - 1102
  • [28] Plasma Levels of Nitrate and Risk of Prostate Cancer: A Prospective Study
    Wu, Tianying
    Wang, Yushan
    Ho, Shuk-Mei
    Giovannucci, Edward
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (07) : 1210 - 1218
  • [29] The Association Between Plasma Fatty Acids and Risk of Lung Cancer: A Prospective Cohort Study of the UK Biobank
    Huang, Jianv
    Li, Jiacong
    He, Lu
    Miao, Junyan
    Zhu, Meng
    Dai, Juncheng
    Jin, Guangfu
    Ma, Hongxia
    Hang, Dong
    Shen, Hongbing
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [30] A PROSPECTIVE-STUDY OF PLASMA PROLACTIN LEVELS AND SUBSEQUENT RISK OF BREAST-CANCER
    KWA, HG
    CLETON, F
    WANG, DY
    BULBROOK, RD
    BULSTRODE, JC
    HAYWARD, JL
    MILLIS, RR
    CUZICK, J
    INTERNATIONAL JOURNAL OF CANCER, 1981, 28 (06) : 673 - 676